CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson's Disease Using Multiomics
CentogeneCentogene(US:CNTG) Newsfilter·2024-01-23 11:30

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and The Michael J. Fox Foundation for Parkinson's Research (MJFF), a non-profit organization dedicated to finding a cure for Parkinson's disease (PD), today announced a research project to accelerate research on genetic risk factors associated with PD, specifically targeting the role of variants i ...